Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man

Journal of Clinical Endocrinology and Metabolism

Volumn 72, Issue 4, 1991, Pages 768-772

  M0ller, Jens ^a   Jorgensen, Jens O L ^a   Moller, Niels ^a   W Hansen, Klavs ^a   Pedersen, Erling B ^a   Christiansen, Jens S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; GROWTH HORMONE; HUMAN GROWTH HORMONE; PLACEBO; SOMATREM;

ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BLOOD VOLUME; BODY WEIGHT; ELECTROLYTES; EXTRACELLULAR SPACE; GROWTH HORMONE; HUMAN; MALE; REFERENCE VALUES; RENIN-ANGIOTENSIN SYSTEM;

EID: 0025756328     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-72-4-768     Document Type: Article

References (35)

1. Ikkos D, Luft R, Sjogren B. Body Water and sodium in patients with acromegaly. J Clin Invest. 1954;33:989-94.
2. Bengtson BA, Brummer RJM, Eden S, Bosaeus I. Body composition in acromegaly. Clin Endocrinol (Oxf). 1989;30:121-30.
3. Falkheden T, Sjogren B. Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly. Acta Endocrinol (Copenh). 1964;46:80-88.
4. Hutchings JJ, Escamilla RF, Deamer WC, Li CH. Metabolic changes produced by human growth hormone (Li) in a pituitary dwarf. J Clin Endocrinol Metab. 1959;19:759-69.
5. Ikkos D, Luft R, Gemzell CA. The effect of human growth hormone in man. Acta Endocrinol (Copenh). 1959;32:341-61.
6. Henneman PH, Forbes AP, Dempsey MMEF, Carroll EL. Effect of growth hormone in man. J Clin Invest. 1960;39:1223-38.
7. Parra A, Argote RM, Garcia G, Cervantes C, Alatorre S, Perez- Pasten E. Body composition in hypopituitary dwarfs before and during human growth hormone therapy. Metabolism. 1979;28:851-57.
8. Beck JC, McGarry EE, Dyrenfurth J, Morgen RO, Bird ED, Venning EH. Primate growth hormone studies in man. Metabolism. 1960;9:699-737.
9. Collipp PJ, Curti V, Thomas J, Sharma RK, Maddaiaha VT, Cohn SH. Body composition changes in children receiving human growth hormone. Metabolism. 1973;22:589-95.
10. Biglieri EG, Watlington CO, Forsham PH. Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab. 1961;21:361-70.
11. Ho KY, Weissberger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves action of the renin-angiotensin system. Metabolism. 1990;39:133-37.
12. Ho KY, Weissberger AJ, Stuart MC, Day RO, Lazarus L. The pharmacokinetics, safety, and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol (Oxf). 1989;30:335-45.
13. Rudman R, Chyatte SB, Patterson JH, Gerron GG, O’Beirne I, Barlow J, Ahmann P, Jordan A, Mosteller RC. Observations on the responsiveness of human subjects to human growth hormone. J Clin Invest. 1971;50:1941-49.
14. McKnight JA, McCance DR, Hadden DR, Kennedy L, Roberts G, Sheridan B, Atkinson AB. Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegaly. Clin Endocrinol (Oxf). 1989;31:431-38.
15. Danielsen H, Pedersen EB, Nielsen AH, Herlevsen P, Kornerup HJ, Posborg V. Expansion of extracellular volume in early polycystic kidney disease. Acta Med Scand. 1986;219:399-405.
16. 82 as a measurement of the extracellular fluid volume in normal persons. Scand J Clin Lab Invest. 1970;25:291-97.
17. Kappelgaard AM, Damkjaer Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976;67:299-306.
18. Rask-Madsen J, Bruunsgaard A, Munck O, Nielsen MD, Worming H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol. 1974;9:417-426.
19. Robertson GL, Mahr EA, Athar S, Sinna T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest. 1973;52:2340-53.
20. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamid on renal plasma flow, glomerular filtration rate, and arginine-vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol. 1984;26:543-547.
21. Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol. 1987;17:270-6.
22. Jorgensen JOL, Flyvbjerg A, Lauritzen T, Alberti KGMM, Orskov H, Christiansen JS. Dose response studies with biosynthetic human growth hormone (GH) in GH deficient patients. J Clin Endocrinol Metab. 1988;67:36-40.
23. Strauch G, Lego A, Therain F, Bricaire H. Reversible plasma and red blood cells volumes increases in acromegaly. Acta Endocrinol (Copen.) 1977;85;465-78.
24. Espiner EA, Richards AM. Atrial natriuretic peptide. An Important factor in sodium and blood pressure regulation. Lancet. 1989:707-710.
25. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 1985;314:364-66.
26. Thuesen L, Christiansen JS, Sorensen KE, Jorgensen JOL, Orskov H, Henningsen P. Increased myocardial contractility following growth hormone administration in normal man. Dan Med Bull. 1988;35:193-96.
27. Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato NS, Weisberg AS, Lubetzki J, Lecarpentier Y, Winegrad S, Mercadier JJ. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest. 1990;86:507-515.
28. Venning EH, Lucis OJ. Effect of growth hormone on the biosynthesis of aldosterone in the rat. Endocrinology. 1962;20:486-91.
29. Birkhauser M, Gaillard R, Riondell AM, Zahnd GR. Influence of acute administration of human growth hormone and alpha MSH on plasma concentrations of aldosterone, cortisol, corticosterone and growth hormone in man. Acta Endocrinol (Copenh). 1975;79:16-24.
30. Venning EH, Dyrenfurth I, Giroud CJP, Beck JC. Effect of growth hormone on aldosterone excretion. Metabolism. 1956;5:697-702.
31. Bengt E Karlberg, Anna-Maria Ottosen. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol (Copenh). 1982;100:581-87.
32. Goetz KL. Physiology and pathophysiology of atrial peptides. Am J Physiol 1988;254:E1-E15.
33. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
34. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 1986;250:E269-73.
35. Bratusch-Marrain PR, Smith D, DeFronzo R. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982;55:973-82.